Prescription Drug Prices; Why are they so high?! Part 1- Regulations

Prescription Drug Prices; Why are they so high?! Part 1- Regulations

Understanding the Inflation Reduction Act and Upcoming Changes to MedicareПодробнее

Understanding the Inflation Reduction Act and Upcoming Changes to Medicare

High Price of Prescription Drugs: Taking Action to Lower CostsПодробнее

High Price of Prescription Drugs: Taking Action to Lower Costs

Why are Brand Name Drugs more Expensive than Generics? | Patrick KellyПодробнее

Why are Brand Name Drugs more Expensive than Generics? | Patrick Kelly

Part I:Pharmacoeconomics | Definition | Reason increase in health care spending & drug cost.Подробнее

Part I:Pharmacoeconomics | Definition | Reason increase in health care spending & drug cost.

FDA Product Regulations Part 1 of 7Подробнее

FDA Product Regulations Part 1 of 7

How Will the Inflation Reduction Act Affect the Cost of Medicines for Patients? | LIVE STREAMПодробнее

How Will the Inflation Reduction Act Affect the Cost of Medicines for Patients? | LIVE STREAM

AZBioPEERS Regulatory Science Part 1Подробнее

AZBioPEERS Regulatory Science Part 1

How to Rein In Sky High Drug Prices?Подробнее

How to Rein In Sky High Drug Prices?

Generic Imatinib: Gaining PerspectiveПодробнее

Generic Imatinib: Gaining Perspective

Opioid Analgesics - Proper Pain Managment, Prescription Drug Abuse and AlternativesПодробнее

Opioid Analgesics - Proper Pain Managment, Prescription Drug Abuse and Alternatives

Patient cost sharing for prescription drugs: Policy Issues - Part 1Подробнее

Patient cost sharing for prescription drugs: Policy Issues - Part 1

Patient cost sharing for prescription drugs: Policy Issues - Part 2Подробнее

Patient cost sharing for prescription drugs: Policy Issues - Part 2

U.S. Drug Prices: Why Are They So High?Подробнее

U.S. Drug Prices: Why Are They So High?

California Board of Pharmacy Meeting (Part 1) - January 4, 2017Подробнее

California Board of Pharmacy Meeting (Part 1) - January 4, 2017

Louisiana’s prescription drug experiment: A model for the nation? - Part 1Подробнее

Louisiana’s prescription drug experiment: A model for the nation? - Part 1

ICER Orphan Drug Assessment and Pricing Summit - Part 1 of 3Подробнее

ICER Orphan Drug Assessment and Pricing Summit - Part 1 of 3

Examining the Drug Supply ChainПодробнее

Examining the Drug Supply Chain

A conversation with CMS Administrator Seema Verma - Part 1Подробнее

A conversation with CMS Administrator Seema Verma - Part 1

Unpacking Policy Options to Promote Prescription Drug AffordabilityПодробнее

Unpacking Policy Options to Promote Prescription Drug Affordability